Lab21 Acquires MDx Firm

Lab21 gains access to a phage amplification technology that it is being used to develop rapid tests for active and drug-resistant tuberculosis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.